Showing results (51-60 of 290) with videos related to
Sort By:
Pageof 29
Cardiovascular Diabetology|December 3, 2004
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?Alexander Tenenbaum, Enrique Z FismanCardiology Journal|August 6, 2013
Optimal revascularization in diabetes after the FREEDOM trial: were the controversies finally settled?Alexander Tenenbaum, Enrique Z FismanCardiovascular Diabetology|November 25, 2021
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospectEnrique Z Fisman, Alexander TenenbaumCardiovascular Diabetology|September 30, 2015
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomesEnrique Z Fisman, Alexander TenenbaumCardiovascular Diabetology|November 16, 2012
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?Alexander Tenenbaum, Enrique Z FismanCardiovascular Diabetology|October 13, 2010
The ubiquitous interleukin-6: a time for reappraisalEnrique Z Fisman, Alexander TenenbaumGynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 2001
Hypertension in menopausal women--a special case, for special treatment?A Pines, E Z FismanAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
ACE Inhibition with moexipril: a review of potential effects beyond blood pressure controlAmos Pines, Enrique Z FismanCardiovascular Diabetology|October 13, 2012
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reductionAlexander Tenenbaum, Enrique Z FismanAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2004
Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategiesAlexander Tenenbaum, Enrique Z FismanPageof 29